Form 4: BioLargo Director Strommen Acquires Options in Lieu of Fees
SEC Form 4 Filing
Director Jack B. Strommen acquired options to purchase 42,857 shares of BioLargo, Inc. (BLGO) common stock in lieu of $15,000 in director fees.
Summary
- On March 31, 2024, Jack B. Strommen, a director of BioLargo, Inc., acquired options to purchase 42,857 shares of common stock.
- The options were granted as payment for $15,000 in director fees for the most recent quarterly period.
- The exercise price of the options is $0.35 per share.
- The options are exercisable immediately and expire on March 31, 2034.
- Following the transaction, Strommen directly owns 1,858,327 shares of BioLargo common stock.
Sentiment
Score: 7
Explanation: The sentiment is neutral to slightly positive. The director receiving options in lieu of cash is a common practice and shows alignment with shareholders. There are no indications of negative news.
Positives
- The issuance of options in lieu of cash fees conserves the company's cash resources.
- The director's continued stock ownership aligns his interests with those of other shareholders.
Industry Context
The use of equity compensation for board members is a common practice, particularly for smaller companies, to conserve cash and align director interests with shareholder value.
Comparison to Industry Standards
- Many small-cap companies use stock options as part of their compensation packages for directors.
- The specific terms of the options, such as the exercise price and expiration date, are generally aligned with industry standards for similar-sized companies.
- Compared to larger companies, BioLargo's reliance on equity compensation may be more pronounced due to cash constraints.
Related Party Transactions
- The issuance of options to director Jack B. Strommen in lieu of cash compensation is a related party transaction.
Stakeholder Impact
- Shareholders: The transaction dilutes existing shareholders slightly but aligns director incentives with shareholder value.
- Employees: No direct impact on employees.
- Company: Conserves cash by using equity instead of cash for director compensation.
Key Dates
| Date | Description |
|---|---|
| 03/31/2024 | Date of the transaction: Strommen acquired options to purchase common stock. |
| 03/31/2024 | Options become exercisable. |
| 03/31/2034 | Expiration date of the options. |
| 04/02/2024 | Date of signature on the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.